Login / Signup

Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study.

Michael T EadonJudith MaddatuSharon M MoeArjun D SinhaRicardo Melo FerreiraBrent W MillerS Jawad SherJing SuVictoria M PrattArlene B ChapmanTodd C SkaarRanjani N Moorthi
Published in: Kidney360 (2022)
There is a potential role for the addition of pharmacogenomic testing to optimize antihypertensive regimens in patients with CKD.
Keyphrases
  • chronic kidney disease
  • blood pressure
  • clinical decision support
  • hypertensive patients